Open Label Study to Compare Efficacy, Safety and Tolerability of Hydroxychloroquine Combined With Azithromycin Compared to Hydroxychloroquine Combined With Camostat Mesylate and to "no Treatment" in SARS CoV 2 Virus

NCT04355052 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

250

Enrollment

OTHER_GOV

Sponsor class

Conditions

COVID - 19

Interventions

DRUG: hydroxychloroquine in combination with camostat mesylate
DRUG: Hydroxychloroquine in combination of Azithromycin

Sponsor

Sheba Medical Center